Back

Immune checkpoint inhibitor (ICI)-induced cardiac toxicity: a clinical case of biventricular dysfunction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology 1 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Michela Boromei

La sapienza, Roma (Italy)

3 More presentations in this session

Presentation thumbnail
A rare presentation of disseminated micronodular melanoma masquerading as an infiltrative cardiomyopathy.
Doctor M. Martinho (Almada, PT)
Slides Video
Presentation thumbnail
An uncommon case of pericardial effusion and Takotsubo cardiomyopathy secondary to azacitidine in a patient with myelodysplastic syndrome
Doctor G. Ooi (Singapore, SG)
Slides Video
Presentation thumbnail
A case of secondary cardiac involvement in a patient with T- and B-cell lymphoma presenting with right sided heart failure and rhythm disorders
Doctor S. Ivanova (Sofia, BG)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Challenges in the management of immune checkpoint inhibitor related myocarditis.
thumbnail
Congress Presentation
A rare case of cardiovascular toxicity caused by pembrolizumab leading to coronary vasospasm
thumbnail
Congress Presentation
Immune checkpoint inhibitor myocarditis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources